| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.24 | 2e-06 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-06 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |